Matinas BioPharma Inc.

MTNB | AMEX

Price Alert Chart Builder DCF Calculator

$1.51

-$0.39 (-20.53%)

At close: Oct 30, 2026, 3:59 PM ET

$1.19

-$0.32 (-21.19%)

Pre-market: Nov 2, 2026, 6:02 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	4M	7.28M	4.79M	6.88M	21.03M	12.43M
Short-Term Investments	n/a	n/a	8.97M	21.93M	28.59M	46.25M
Long-Term Investments	200K	200K	n/a	200K	n/a	n/a
Other Long-Term Assets	n/a	n/a	200K	n/a	200K	199.95K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	76K	741K	50K	5.72M	49.53K	136K
Total Current Assets	4.08M	8.03M	15.54M	34.53M	50.99M	61.55M
Property-Plant & Equipment	673K	2.16M	5.01M	5.73M	5.78M	4.86M
Goodwill & Intangibles	2.26M	2.26M	4.35M	4.35M	4.35M	4.35M
Total Long-Term Assets	3.13M	4.62M	9.56M	44.33M	10.33M	9.41M
Total Assets	7.21M	12.64M	25.1M	78.87M	61.33M	70.97M
Account Payables	315K	95K	514K	618K	937K	349.94K
Deferred Revenue	n/a	n/a	n/a	809K	33K	643K
Short-Term Debt	696K	n/a	n/a	569K	n/a	n/a
Other Current Liabilities	452K	4K	271K	585K	899K	329
Total Current Liabilities	1.46M	2.67M	2.62M	4.29M	4.35M	3.57M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	915K	2.39M	3.24M	37.94M	4.48M	3.67M
Total Liabilities	2.38M	5.05M	5.86M	42.23M	8.83M	7.24M
Total Debt	1.35M	2.89M	3.56M	4.12M	4.7M	3.75M
Book Value	4.83M	7.59M	19.25M	36.64M	52.49M	63.73M
Book Value Per Share	13.23	23.40	66.44	126.74	187.32	242.76
Common Stock	1K	1K	22K	22K	22K	20.01K
Retained Earnings	-210.79M	-199.82M	-175.57M	-152.63M	-131.63M	-107.51M
Comprehensive Income	n/a	n/a	-221K	-824K	-145K	228.17K
Shareholders Equity	4.83M	7.59M	19.25M	36.64M	52.49M	63.73M
Total Investments	200K	200K	8.97M	22.13M	28.59M	46.25M